Q3 2022 Holdings
Filed 2022-11-10 | 192 holdings | $23.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alphabet Inc Class C(GOOG) | Common | 02079K107 | $10.8M | 112,220 | 46.1% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $2.7M | 20,037 | 11.5% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $1.9M | 200,000 | 8.2% |
| Chesapeake Energy Corporation(EXE) | Common | 165167735 | $1.9M | 20,000 | 8.0% |
| Bridgebio Pharma, Inc.(BBIO) | Common | 10806X102 | $1.4M | 143,096 | 6.1% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $1.3M | 222,107 | 5.8% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $774.0K | 650,000 | 3.3% |
| Aadi Bioscience, Inc.(WHWK) | Common | 00032Q104 | $693.0K | 49,039 | 3.0% |
| Corteva, Inc.(CTVA) | Common | 22052L104 | $661.0K | 11,563 | 2.8% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $607.0K | 80,694 | 2.6% |
| Adma Biologics, Inc.(ADMA) | Common | 000899104 | $370.0K | 152,301 | 1.6% |
| Calumet Specialty Products Partners, LP | Common | 131476103 | $55.4K | 4,325,000 | 0.2% |
| Amazon Inc.(AMZN) | Common | 023135106 | $34.0K | 300 | 0.1% |
| DocGo, Inc.(DCGO) | Common | 256086109 | $13.9K | 1,400,000 | 0.1% |
| Apollo Global Management, Inc.(APO) | Common | 03769M106 | $10.5K | 225,000 | 0.0% |
| Ligand Pharmaceuticals Incorporated(LGND) | Common | 53220K504 | $9.9K | 115,000 | 0.0% |
| Franklin BSP Realty Trust, Inc.(FBRT) | Common | 35243J101 | $9.3K | 859,047 | 0.0% |
| Fortress Trans & Infrastructure Inv. LLC | Common | 34960P101 | $6.4K | 425,000 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $6.3K | 143,500 | 0.0% |
| Coliseum Acquisition Corp. Wts | Common | G2263T107 | $5.7K | 495,000 | 0.0% |
| African Gold Acquistion Corp. Warrants | Common | G0112R124 | $5.2K | 450,750 | 0.0% |
| Midwest Holding Inc. | Common | 59833J206 | $5.2K | 390,241 | 0.0% |
| Vertex Pharmaceuticals, Inc.(VRTX) | Common | 92532F100 | $4.9K | 17,000 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $4.1K | 24,800 | 0.0% |
| CTI BioPharma Corp.(CTIC1USD) | Common | 12648L601 | $3.3K | 566,687 | 0.0% |
| Eiger BioPharmaceuticals, Inc.(CLDNEUR) | Common | 28249U105 | $3.1K | 409,292 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | Common | G50871105 | $3.0K | 22,411 | 0.0% |
| Glass Houses Acquisition Corp. Warrants | Common | 37714P111 | $2.9K | 250,000 | 0.0% |
| Kennedy-Wilson Holdings, Inc.(KW) | Common | 489398107 | $2.7K | 175,000 | 0.0% |
| Horizon Therapeutics Public Ltd. Company | Common | G46188101 | $2.7K | 43,490 | 0.0% |
| Xenon Pharmaceuticals Inc.(XENE) | Common | 98420N105 | $2.1K | 59,500 | 0.0% |
| JP Morgan Chase(JPM) | Common | 46625H100 | $2.1K | 20,385 | 0.0% |
| iPath Series B S&P 500 VIX Short-Term Fut | Common | 06747R477 | $2.1K | 100,000 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $2.1K | 24,500 | 0.0% |
| Medicus Science Acquisition, Corp. | Common | G5960S108 | $2.0K | 200,000 | 0.0% |
| Avadel Pharmaceuticals plc | Common | 05337M104 | $2.0K | 390,861 | 0.0% |
| Twelve Seas Investment Company II Warrants | Common | 90118T114 | $1.9K | 166,666 | 0.0% |
| Ryman Hospitality Properties, Inc.(RHP) | Common | 78377T107 | $1.8K | 24,400 | 0.0% |
| AllianceBernstein Holding L.P.(AB) | Common | 01881G106 | $1.8K | 50,500 | 0.0% |
| The Mosaic Company(MOS) | Common | 61945C103 | $1.7K | 35,000 | 0.0% |
| Kiwetinohk Energy Corp. | Common | 49836K102 | $1.6K | 160,000 | 0.0% |
| Brookfield Infrastructure Partners L.P.(BIP) | Common | G16252101 | $1.6K | 45,000 | 0.0% |
| Ovintiv Inc.(OVV) | Common | 69047Q102 | $1.6K | 35,000 | 0.0% |
| Kairos Acquisition Corp. Warrants | Common | G52110106 | $1.6K | 139,278 | 0.0% |
| Teck Resources Ltd.(TECK) | Common | 878742204 | $1.5K | 50,000 | 0.0% |
| Calumet Specialty Products Partners, LPCall | Common | 131476103 | $1.5K | 115,000 | 0.0% |
| Cenovus Energy Inc.(CVE) | Common | 15135U109 | $1.5K | 95,000 | 0.0% |
| B.Riley Principal 250 Merger Corp. Wts. | Common | 05602L112 | $1.3K | 116,666 | 0.0% |
| F-Star Therapeutics, Inc. | Common | 30315R107 | $1.2K | 235,945 | 0.0% |
| GlaxoSmithKline plc | Common | 37733W105 | $1.2K | 40,000 | 0.0% |